Andreas Heibges

1.1k total citations
24 papers, 698 citations indexed

About

Andreas Heibges is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Andreas Heibges has authored 24 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Andreas Heibges's work include Lipoproteins and Cardiovascular Health (12 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Andreas Heibges is often cited by papers focused on Lipoproteins and Cardiovascular Health (12 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Andreas Heibges collaborates with scholars based in Germany, Japan and United States. Andreas Heibges's co-authors include Reinhard Klingel, Cordula Fassbender, Francesco Salamini, Christiane Gebhardt, Walter Lehmacher, Ulrich Julius, Franz Heigl, E. Roeseler, Josef Leebmann and Dennis Heutling and has published in prestigious journals such as Circulation, The American Journal of Cardiology and Biosensors and Bioelectronics.

In The Last Decade

Andreas Heibges

22 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Heibges Germany 14 320 138 130 104 103 24 698
Gabriele Spohn Germany 14 157 0.5× 207 1.5× 29 0.2× 131 1.3× 6 0.1× 24 813
J.-B. Michel France 9 285 0.9× 164 1.2× 266 2.0× 115 1.1× 14 0.1× 16 884
Wouter Peeters Netherlands 14 172 0.5× 292 2.1× 311 2.4× 193 1.9× 7 0.1× 22 948
Zhi-Han Tang China 10 173 0.5× 249 1.8× 38 0.3× 209 2.0× 7 0.1× 14 642
Shanshan Yu China 14 91 0.3× 350 2.5× 44 0.3× 46 0.4× 17 0.2× 30 683
Minna Tamminen Finland 14 182 0.6× 170 1.2× 60 0.5× 101 1.0× 8 0.1× 19 685
Louis Villeneuve Canada 12 65 0.2× 269 1.9× 491 3.8× 43 0.4× 12 0.1× 26 702
Yanping Le China 17 140 0.4× 916 6.6× 69 0.5× 70 0.7× 38 0.4× 32 1.3k
Sandra Camino-López Spain 12 175 0.5× 233 1.7× 91 0.7× 115 1.1× 5 0.0× 13 586
Hamish Prosser Australia 14 216 0.7× 226 1.6× 178 1.4× 65 0.6× 5 0.0× 18 684

Countries citing papers authored by Andreas Heibges

Since Specialization
Citations

This map shows the geographic impact of Andreas Heibges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Heibges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Heibges more than expected).

Fields of papers citing papers by Andreas Heibges

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Heibges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Heibges. The network helps show where Andreas Heibges may publish in the future.

Co-authorship network of co-authors of Andreas Heibges

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Heibges. A scholar is included among the top collaborators of Andreas Heibges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Heibges. Andreas Heibges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klingel, Reinhard, Wanja M. Bernhardt, Franz Heigl, et al.. (2025). Lipoprotein apheresis for lipoprotein(a)-associated progressive atherosclerotic cardiovascular disease: 12-years follow-up. Atherosclerosis. 410. 120508–120508.
2.
Taylan, Christina, Claus Peter Schmitt, Lars Pape, et al.. (2020). Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis. The American Journal of Cardiology. 136. 38–48. 7 indexed citations
3.
Klingel, Reinhard, Andreas Heibges, & Cordula Fassbender. (2019). Lipoprotein(a) and mortality—a high risk relationship. PubMed. 14(S1). 13–19. 11 indexed citations
4.
Klingel, Reinhard, Franz Heigl, Volker Schettler, et al.. (2019). Lipoprotein(a) – Marker for cardiovascular risk and target for lipoprotein apheresis. Atherosclerosis Supplements. 40. 17–22. 8 indexed citations
5.
Klaus, Günter, Christina Taylan, Rainer Büscher, et al.. (2018). Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity. Pediatric Nephrology. 33(7). 1199–1208. 9 indexed citations
6.
7.
Klingel, Reinhard, Andreas Heibges, & Cordula Fassbender. (2015). Lipoprotein apheresis for Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease – Additional particular aspects of the Pro(a)LiFe multicenter trial. Atherosclerosis Supplements. 18. 35–40. 13 indexed citations
8.
Fassbender, Cordula & Andreas Heibges. (2014). Therapeutische Apherese – Kostenerstattung in Deutschland. Dialyse aktuell. 17(10). 531–534.
9.
Leebmann, Josef, E. Roeseler, Ulrich Julius, et al.. (2013). Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular Disease. Circulation. 128(24). 2567–2576. 232 indexed citations
10.
Klingel, Reinhard, Andreas Heibges, & Cordula Fassbender. (2013). Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies – Perspectives for immunoadsorption. Atherosclerosis Supplements. 14(1). 161–165. 22 indexed citations
11.
Heibges, Andreas, et al.. (2012). Long‐term strategies for the treatment of Refsum's disease using therapeutic apheresis. Journal of Clinical Apheresis. 27(2). 99–105. 18 indexed citations
12.
Straube, Richard, et al.. (2010). Rheopherese bei rezidivierendem Hörsturz. HNO. 58(5). 445–451. 10 indexed citations
13.
Klingel, Reinhard, et al.. (2010). RheoNet Registry Analysis of Rheopheresis for Microcirculatory Disorders With a Focus on Age‐Related Macular Degeneration. Therapeutic Apheresis and Dialysis. 14(3). 276–286. 22 indexed citations
14.
Klingel, Reinhard, Andreas Heibges, & Cordula Fassbender. (2009). Plasma exchange and immunoadsorption for autoimmune neurologic diseases – current guidelines and future perspectives. Atherosclerosis Supplements. 10(5). 129–132. 35 indexed citations
15.
Klingel, Reinhard, et al.. (2009). Rheopheresis for sudden sensorineural hearing loss. Atherosclerosis Supplements. 10(5). 102–106. 14 indexed citations
16.
Mösges, Ralph, et al.. (2008). Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial. European Archives of Oto-Rhino-Laryngology. 266(7). 943–953. 50 indexed citations
17.
18.
Heibges, Andreas, et al.. (2003). Structural diversity and organization of three gene families for Kunitz-type enzyme inhibitors from potato tubers ( Solanum tuberosum L.). Molecular Genetics and Genomics. 269(4). 526–534. 58 indexed citations
19.
Heibges, Andreas, et al.. (2002). Members of the Kunitz-type protease inhibitor gene family of potato inhibit soluble tuber invertase in vitro. Potato Research. 45(2-4). 163–176. 35 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriele Spohn Breakdown of academic impact, for papers by J.-B. Michel Breakdown of academic impact, for papers by Wouter Peeters Breakdown of academic impact, for papers by Zhi-Han Tang Breakdown of academic impact, for papers by Shanshan Yu Breakdown of academic impact, for papers by Minna Tamminen Breakdown of academic impact, for papers by Louis Villeneuve Breakdown of academic impact, for papers by Yanping Le Breakdown of academic impact, for papers by Sandra Camino-López Breakdown of academic impact, for papers by Hamish Prosser
Rankless by CCL
2026